Exact Mass: 423.9785778
Exact Mass Matches: 423.9785778
Found 65 metabolites which its exact mass value is equals to given mass value 423.9785778,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
(2S,5S,7S)-10-Dechlorodysideathiazole|10-Dechlorodysideathiazole
2-[2-(acetylamino)-4-amino-5-methoxyphenyl]-5-amino-7-bromo-4-chloro-2H-benzotriazole
4-(5-Bromo-thiophene-2-sulfonyl)-2-methyl-piperazine-1-carboxylic acid tert-butyl ester
C14H21BrN2O4S2 (424.01260460000003)
[5-(trifluoromethylsulfonyloxy)naphthalen-1-yl] trifluoromethanesulfonate
Naphthalene-2,3-diyl bis(trifluoromethanesulfonate)
2-Naphthalenecarboxylic acid, 3-hydroxy-4-(4-methyl-3-sulfophenyl)azo-, calcium salt
4,5-Dihydroxy-3-(phenyldiazenyl)naphthalene-2,7-disulfonic acid
Adenosine-diphosphate
COVID info from COVID-19 Disease Map, WikiPathways Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
N-(3-chlorophenyl)-4-fluoro-3-(thiophen-2-ylmethylsulfamoyl)benzamide
ADP(3-)
A nucleoside 5-diphosphate(3-) arising from deprotonation of all three diphosphate OH groups of adenosine 5-diphosphate (ADP); major species present at pH 7.3.
dGDP(3-)
A 2-deoxyribonucleoside 5-diphosphate obtained by deprotonation of the diphosphate OH groups of dGDP.
8-oxo-dADP(3-)
An organophosphate oxoanion obtained by deprotonation of the diphosphate OH groups of 8-oxo-dADP.
KSI-3716
C17H11BrCl2N2O2 (423.93809059999995)
KSI-3716 is a potent c-Myc inhibitor that blocks c-MYC/MAX binding to target gene promoters. KSI-3716 is an effective intravesical chemotherapy agent for bladder cancer[1].
(1r,3r,5s,6e,9s,10s,12r)-9-bromo-3-(3-bromopropa-1,2-dien-1-yl)-12-chloro-5-methyl-4,13-dioxabicyclo[8.2.1]tridec-6-ene
(2r,5s,7s)-2-(1-bromopropyl)-5,7-dichloro-8-[(2e)-pent-2-en-4-yn-1-yl]oxocan-4-yl acetate
C17H23BrCl2O3 (424.02075279999997)
2-(1-bromopropyl)-5,7-dichloro-8-(pent-2-en-4-yn-1-yl)oxocan-4-yl acetate
C17H23BrCl2O3 (424.02075279999997)
(2r,4s,5s,7s,8s)-2-[(1s)-1-bromopropyl]-5,7-dichloro-8-[(2e)-pent-2-en-4-yn-1-yl]oxocan-4-yl acetate
C17H23BrCl2O3 (424.02075279999997)
(2r,3r,5e)-1-[(2s,3s,5r,6r)-5-bromo-3-chloro-6-ethyloxan-2-yl]-3-chlorooct-5-en-7-yn-2-yl acetate
C17H23BrCl2O3 (424.02075279999997)
(5e)-1-[(2r,3r,5r,6s)-5-bromo-3-chloro-6-ethyloxan-2-yl]-3-chlorooct-5-en-7-yn-2-yl acetate
C17H23BrCl2O3 (424.02075279999997)
(2r,4s,5s,7s,8s)-2-[(1s)-1-bromopropyl]-5,7-dichloro-8-[(2z)-pent-2-en-4-yn-1-yl]oxocan-4-yl acetate
C17H23BrCl2O3 (424.02075279999997)
2-(1-bromopropyl)-5,7-dichloro-8-[(2e)-pent-2-en-4-yn-1-yl]oxocan-4-yl acetate
C17H23BrCl2O3 (424.02075279999997)
3-(3,3-dichloro-2-methylpropyl)-1,4-dimethyl-6-(3,3,3-trichloro-2-methylpropyl)piperazine-2,5-dione
9-bromo-3-(3-bromopropa-1,2-dien-1-yl)-12-chloro-5-methyl-4,13-dioxabicyclo[8.2.1]tridec-7-ene
(3s,6s)-3-[(2s)-3,3-dichloro-2-methylpropyl]-1,4-dimethyl-6-[(2s)-3,3,3-trichloro-2-methylpropyl]piperazine-2,5-dione
(2s,3ar,5r,7s,8r,9ar)-2-(3-bromopropa-1,2-dien-1-yl)-5-(1-bromopropyl)-octahydro-2h-furo[3,2-b]oxocine-7,8-diol
(1r,3s,5s,6e,9s,10s,12r)-9-bromo-3-(3-bromopropa-1,2-dien-1-yl)-12-chloro-5-methyl-4,13-dioxabicyclo[8.2.1]tridec-6-ene
(2s,3r,4s,5s,7r)-3-(bromomethyl)-5-chloro-7-[(1r,3z)-1-chlorohex-3-en-5-yn-1-yl]-2-ethyloxepan-4-yl acetate
C17H23BrCl2O3 (424.02075279999997)
(2r,4s,5s,7s,8s)-2-[(1r)-1-bromopropyl]-5,7-dichloro-8-[(2z)-pent-2-en-4-yn-1-yl]oxocan-4-yl acetate
C17H23BrCl2O3 (424.02075279999997)
9-bromo-3-(3-bromopropa-1,2-dien-1-yl)-12-chloro-5-methyl-4,13-dioxabicyclo[8.2.1]tridec-6-ene
3-(bromomethyl)-5-chloro-7-(1-chlorohex-3-en-5-yn-1-yl)-2-ethyloxepan-4-yl acetate
C17H23BrCl2O3 (424.02075279999997)
(3s)-4,4-dichloro-3-methyl-n-[(1s,3s)-4,4,4-trichloro-3-methyl-1-(1,3-thiazol-2-yl)butyl]butanimidic acid
(2r,4s,5s,7s,8s)-2-[(1r)-1-bromopropyl]-5,7-dichloro-8-(pent-2-en-4-yn-1-yl)oxocan-4-yl acetate
C17H23BrCl2O3 (424.02075279999997)
6,7,8,17,18-pentahydroxy-3,10,15,22-tetraoxahexacyclo[14.6.2.0²,¹¹.0⁴,⁹.0¹³,²³.0²⁰,²⁴]tetracosa-1,4,6,8,11,13(23),16(24),17,19-nonaene-14,21-dione
(2s,3ar,5r,7s,8r,9ar)-2-(3-bromopropa-1,2-dien-1-yl)-5-[(1r)-1-bromopropyl]-octahydro-2h-furo[3,2-b]oxocine-7,8-diol
(2s,3ar,5r,7s,8r,9ar)-2-(3-bromopropa-1,2-dien-1-yl)-5-[(1s)-1-bromopropyl]-octahydro-2h-furo[3,2-b]oxocine-7,8-diol
4,4-dichloro-3-methyl-n-[4,4,4-trichloro-3-methyl-1-(1,3-thiazol-2-yl)butyl]butanimidic acid
(2r,4s,5s,7s,8s)-2-[(1r)-1-bromopropyl]-5,7-dichloro-8-[(2e)-pent-2-en-4-yn-1-yl]oxocan-4-yl acetate
C17H23BrCl2O3 (424.02075279999997)
(1r,3r,5s,6z,9s,10s,12r)-9-bromo-3-(3-bromopropa-1,2-dien-1-yl)-12-chloro-5-methyl-4,13-dioxabicyclo[8.2.1]tridec-6-ene
(3r,6r)-3-[(2r)-3,3-dichloro-2-methylpropyl]-1,4-dimethyl-6-[(2s)-3,3,3-trichloro-2-methylpropyl]piperazine-2,5-dione
(1r,3r,5s,7z,9s,10s,12r)-9-bromo-3-(3-bromopropa-1,2-dien-1-yl)-12-chloro-5-methyl-4,13-dioxabicyclo[8.2.1]tridec-7-ene
(4s,5s,7s,8s)-2-[(1r)-1-bromopropyl]-5,7-dichloro-8-[(2z)-pent-2-en-4-yn-1-yl]oxocan-4-yl acetate
C17H23BrCl2O3 (424.02075279999997)